Med BioGene Inc. Comments on Market Activity
May 17, 2013 22:24 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 17, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today, at the request of the Investment Industry Regulatory Organization of Canada (IIROC),...
Med BioGene Announces Adoption of Advance Notice Policy
April 18, 2013 14:47 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 18, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its board of directors (the "Board") has adopted an Advance Notice...
Med BioGene Announces Date of Annual and Special Meeting
April 15, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 15, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced the date of its upcoming annual and special meeting of shareholders...
Med BioGene Reports Financial Results for 2012
April 09, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 9, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for 2012 (all amounts are in United States dollars).
...
Med BioGene Announces New Marketing Name for Lung Cancer Test
March 27, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 27, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its commercial partner, Precision Therapeutics, Inc., has decided upon...
Med Biogene Provides Update on Litigation With Signal Genetics LLC and Respira Health LLC
February 25, 2013 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 25, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update in regard to its ongoing litigation with Signal Genetics LLC and...
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx(TM) Clinical Studies; Precision Therapeutics Prepares for Commercial Launch
January 23, 2013 08:30 ET
|
Precision Therapeutics, Inc.;Med BioGene Inc.
PITTSBURGH, PENNSYLVANIA and VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 23, 2013) - Precision Therapeutics, Inc. and Med BioGene Inc. (TSX VENTURE:MBI) today announced that Precision...
Med BioGene Reports Financial Results for Q3 2012
November 29, 2012 22:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 29, 2012) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the nine months ended September 30, 2012 (all...
Med BioGene Provides Update
October 03, 2012 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 3, 2012) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update regarding the commercialization of LungExpress Dx and ongoing...
Med BioGene Reports Financial Results for Q2 2012
August 29, 2012 19:15 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 29, 2012) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the six months ended June 30, 2012 (all amounts are...